Ireland· IE-PA-PPA0465/413/001
Alphagan 0.2% w/v (2 mg/ml) eye drops, solution
A brimonidine product containing brimonidine tartrate, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Brimonidine is registered in 12 of 19 countries.
Countries holding a registration under ATC S01EA05 (brimonidine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Brimonidine · ATC S01EA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Brimonidine tartrate
- Manufacturer
- PCO Manufacturing Ltd.
- Country
- Ireland (IE)
- ATC code
- S01EA05
- ATC class
- Brimonidine
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA0465/413/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
567 interactions on record for brimonidine.
Graded by severity as the source publishes them — 387 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brimonidine · interactions on record
567 records
- 387 moderate
- 180 info
Most severe, free to view
- PapaverineA03AD01moderate
- MetoclopramideA03FA01moderate
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brimonidine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALPHAGANAbbVie s.r.o., Praha
- PolandAlphaganAbbVie Sp. z o.o.
- FranceALPHAGAN 0,2 % (2mg/ml), collyre en solutionABBVIE
- SwedenAlphagan 0,2 % (2 mg/ml) Ögondroppar, lösningAbbVie AB
- NetherlandsAlphagan 0,2% g/v (2 mg/ml) oogdruppels, oplossingAbbVie B.V.
- United StatesBrimonidine tartrateMicro Labs Limited
- FinlandBrimonidin SandozSandoz A/S
- NorwayAlphaganAbbVie AS
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Alpha-Vision Sine, Alphagan
- Belgium · Alphagan, Lumobry
- Bulgaria · Brimogen, Бримонидин Абр
- Cyprus · Brimontal, Corneax
- Czechia · Alphagan, Brimonidin Olikla
- Germany · Alphagan, Brimo-Vision
- Denmark · Alphagan, Brimonidintartrat 1a Farma
- Spain · Abradel, Alphagan
- Finland · Alphagan, Lumobry
- France · Alphagan, Brimazed
- United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
- Greece · Alphagan, Brimofree
- Croatia · Alphagan, Bimanox
- Hungary · Brimogen, Lumobry
- Iceland · Alphagan, Brimonidin Bluefish
- Italy · Alphagan, Brimofree
- Liechtenstein · Mirvaso
- Lithuania · Brimonal, Brimonidine Tartrate Elvim
- Luxembourg · Alphagan, Brimonidin Micro Labs
- Latvia · Briglafre, Brimonal
- Malta · Alphagan, Brimogan
- Netherlands · Alphagan, Brimonidine Stulln
- Norway · Alphagan, Brymont
- Poland · Alphagan, Biprolast
- Portugal · Alphagan, Bglau
- Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
- Sweden · Alphagan, Brimonidin Bluefish
- Slovenia · Bimanox, Luvify
- Slovakia · Brimonal, Brimonidin Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac7ffa89-8d94-4f37-b9a3-0aa16219915e GET /v1/drugs/ac7ffa89-8d94-4f37-b9a3-0aa16219915e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S01EA05"
],
"strength": null,
"pa_number": "PPA0465/413/001",
"substances": [
"Brimonidine tartrate"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "01/07/2015",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about brimonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.